Anavex Life Sciences Corp. (NASDAQ:AVXL)

Monday, August 3, 2015 | Web News
Disclosure: GeoInvesting is providing this information for your edification and in no way has any affiliation with any promoters and/or newsletters disseminating information on AVXL, nor is...
Tuesday, June 4, 2013 | Web News
Disclosure: GeoInvesting is providing this information for your edification and in no way has any affiliation with any promoters and/or newsletters disseminating information on AVXL, nor is...
See All Research...
Monday, May 2, 2016, 9:31 AM
Anavex Life Sciences: $200,000 Penny Stock Promotional Campaign Should End Badly
See All Articles and Reports...

Anavex Life Sciences Corp. is a pharmaceutical company engaged in the development of novel drug candidates.  ANAVEX 2-73, a drug candidate developed to treat Alzheimer's disease through disease modification, has undergone an initial Phase 1 human clinical trial and was well tolerated in doses up to 55mg. Sponsored pre-clinical studies indicate that ANAVEX 2-73 demonstrates anti-amnesic and neuroprotective properties.  Anavex is a publicly traded corporation quoted as AVXL.

Web site: http://www.anavex.com

Last updated August 3, 2015